Evidence map›Paper›PMID 38283073›Full record

ArticleACS catalysis2023

CdS Quantum Dots for Metallaphotoredox-Enabled Cross-Electrophile Coupling of Aryl Halides with Alkyl Halides.

Julianna M Mouat, Jonas K Widness, Daniel G Enny, Mahilet T Meidenbauer, Farwa Awan, Todd D Krauss, Daniel J Weix

Abstract read
In one paragraph

Article in ACS catalysis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Recyclable dual Z-scheme perovskite/g-CNature communications · 2026
    Article
  2. Article
  3. Cooperative Photoredox Catalysis Under Confinement.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Julianna M MouatDepartment of Chemistry, University of Wisconsin-Madison, 1101 University Ave, Madison, WI 53706 USA.
Jonas K WidnessDepartment of Chemistry, University of Wisconsin-Madison, 1101 University Ave, Madison, WI 53706 USA.
Daniel G EnnyDepartment of Chemistry, University of Wisconsin-Madison, 1101 University Ave, Madison, WI 53706 USA.
Mahilet T MeidenbauerMaterials Science Program, University of Rochester, Rochester, NY 14627 USA.
Farwa AwanDepartment of Chemistry, University of Rochester, Rochester, NY 14627 USA.
Todd D KraussDepartment of Chemistry, University of Rochester, Rochester, NY 14627 USA.
Daniel J WeixDepartment of Chemistry, University of Wisconsin-Madison, 1101 University Ave, Madison, WI 53706 USA.

Funding

QExactive (Orbitrap) mass spectrometerS10OD020022 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI VESTLING, MARTHA M · 2015 to 2015
$483k
Technology Development: Tailored Nano-Molecular Systems for New Modes of ReactivityR21GM141622 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI KRAUSS, TODD D, WEIX, DANIEL JOHN · 2021 to 2022
$427k
NIGMS NIH HHS R21 GM141622NIH HHS S10 OD020022
6 · The paper itself

Abstract

Semiconductor quantum dots (QDs) offer many advantages as photocatalysts for synthetic photoredox catalysis, but no reports have explored the use of QDs with nickel catalysts for C-C bond formation. We show here that 5.7 nm CdS QDs are robust photocatalysts for photoredox-promoted cross-electrophile coupling (40 000 TON). These conditions can be utilized on small scale (96-well plate) or adapted to flow. NMR studies show that triethanolamine (TEOA) capped QDs are the active catalyst and that TEOA can displace native phosphonate and carboxylate ligands, demonstrating the importance of QD surface chemistry.

Indexed as

C–C bond formationcross-electrophile couplingnanoplateletnickelphotochemistryquantum dot

Identifiers

PMID38283073
PMCPMC10812861

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.